vs
LifeStance Health Group, Inc.（LFST）与Pennant Group, Inc.（PNTG）财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是Pennant Group, Inc.的1.3倍（$382.2M vs $289.3M）。LifeStance Health Group, Inc.净利率更高（3.1% vs 3.0%，领先0.1%）。Pennant Group, Inc.同比增速更快（53.2% vs 17.4%）。LifeStance Health Group, Inc.自由现金流更多（$46.6M vs $17.4M）。过去两年Pennant Group, Inc.的营收复合增速更高（35.8% vs 12.8%）
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
Pennant Group, Inc.是一家总部位于美国的医疗服务企业，主营家庭健康护理、临终关怀、长者居住服务及专业护理服务，业务覆盖美国数十个州，核心服务对象为老年及有特殊医疗需求的弱势人群。
LFST vs PNTG — 直观对比
营收规模更大
LFST
是对方的1.3倍
$289.3M
营收增速更快
PNTG
高出35.7%
17.4%
净利率更高
LFST
高出0.1%
3.0%
自由现金流更多
LFST
多$29.3M
$17.4M
两年增速更快
PNTG
近两年复合增速
12.8%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $382.2M | $289.3M |
| 净利润 | $11.7M | $8.6M |
| 毛利率 | — | — |
| 营业利润率 | 4.7% | 6.0% |
| 净利率 | 3.1% | 3.0% |
| 营收同比 | 17.4% | 53.2% |
| 净利润同比 | 264.1% | 50.0% |
| 每股收益（稀释后） | — | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LFSTPNTG
| Q4 25 | $382.2M | $289.3M | ||
| Q3 25 | $363.8M | $229.0M | ||
| Q2 25 | $345.3M | $219.5M | ||
| Q1 25 | $333.0M | $209.8M | ||
| Q4 24 | $325.5M | $188.9M | ||
| Q3 24 | $312.7M | $180.7M | ||
| Q2 24 | $312.3M | $168.7M | ||
| Q1 24 | $300.4M | $156.9M |
净利润LFSTPNTG
| Q4 25 | $11.7M | $8.6M | ||
| Q3 25 | $1.1M | $6.1M | ||
| Q2 25 | $-3.8M | $7.1M | ||
| Q1 25 | $709.0K | $7.8M | ||
| Q4 24 | $-7.1M | $5.8M | ||
| Q3 24 | $-6.0M | $6.2M | ||
| Q2 24 | $-23.3M | $5.7M | ||
| Q1 24 | $-21.1M | $4.9M |
营业利润率LFSTPNTG
| Q4 25 | 4.7% | 6.0% | ||
| Q3 25 | 2.0% | 4.5% | ||
| Q2 25 | -0.9% | 5.3% | ||
| Q1 25 | 0.5% | 6.0% | ||
| Q4 24 | 0.3% | 4.9% | ||
| Q3 24 | 0.0% | 6.0% | ||
| Q2 24 | -5.1% | 5.7% | ||
| Q1 24 | -5.6% | 5.4% |
净利率LFSTPNTG
| Q4 25 | 3.1% | 3.0% | ||
| Q3 25 | 0.3% | 2.7% | ||
| Q2 25 | -1.1% | 3.2% | ||
| Q1 25 | 0.2% | 3.7% | ||
| Q4 24 | -2.2% | 3.0% | ||
| Q3 24 | -1.9% | 3.4% | ||
| Q2 24 | -7.5% | 3.4% | ||
| Q1 24 | -7.0% | 3.1% |
每股收益（稀释后）LFSTPNTG
| Q4 25 | — | $0.25 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | — | $0.20 | ||
| Q1 25 | — | $0.22 | ||
| Q4 24 | — | $0.16 | ||
| Q3 24 | — | $0.20 | ||
| Q2 24 | — | $0.18 | ||
| Q1 24 | — | $0.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $248.6M | — |
| 总债务越低越好 | $282.8M | $168.8M |
| 股东权益账面价值 | $1.5B | $374.3M |
| 总资产 | $2.2B | $968.2M |
| 负债/权益比越低杠杆越低 | 0.19× | 0.45× |
8季度趋势，按日历期对齐
现金及短期投资LFSTPNTG
| Q4 25 | $248.6M | — | ||
| Q3 25 | $203.9M | — | ||
| Q2 25 | $188.9M | — | ||
| Q1 25 | $134.3M | — | ||
| Q4 24 | $154.6M | — | ||
| Q3 24 | $102.6M | — | ||
| Q2 24 | $87.0M | — | ||
| Q1 24 | $49.5M | — |
总债务LFSTPNTG
| Q4 25 | $282.8M | $168.8M | ||
| Q3 25 | $284.6M | $26.0M | ||
| Q2 25 | $286.4M | $37.0M | ||
| Q1 25 | $288.2M | $52.5M | ||
| Q4 24 | $290.0M | $0 | ||
| Q3 24 | $287.3M | $108.9M | ||
| Q2 24 | $288.0M | $82.2M | ||
| Q1 24 | $288.8M | $83.3M |
股东权益LFSTPNTG
| Q4 25 | $1.5B | $374.3M | ||
| Q3 25 | $1.5B | $343.0M | ||
| Q2 25 | $1.5B | $333.6M | ||
| Q1 25 | $1.5B | $323.0M | ||
| Q4 24 | $1.4B | $312.0M | ||
| Q3 24 | $1.4B | $187.3M | ||
| Q2 24 | $1.4B | $173.0M | ||
| Q1 24 | $1.4B | $164.2M |
总资产LFSTPNTG
| Q4 25 | $2.2B | $968.2M | ||
| Q3 25 | $2.1B | $753.6M | ||
| Q2 25 | $2.1B | $751.4M | ||
| Q1 25 | $2.1B | $743.6M | ||
| Q4 24 | $2.1B | $679.5M | ||
| Q3 24 | $2.1B | $646.8M | ||
| Q2 24 | $2.1B | $602.5M | ||
| Q1 24 | $2.1B | $578.2M |
负债/权益比LFSTPNTG
| Q4 25 | 0.19× | 0.45× | ||
| Q3 25 | 0.19× | 0.08× | ||
| Q2 25 | 0.19× | 0.11× | ||
| Q1 25 | 0.20× | 0.16× | ||
| Q4 24 | 0.20× | 0.00× | ||
| Q3 24 | 0.20× | 0.58× | ||
| Q2 24 | 0.20× | 0.48× | ||
| Q1 24 | 0.20× | 0.51× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.6M | $21.0M |
| 自由现金流经营现金流 - 资本支出 | $46.6M | $17.4M |
| 自由现金流率自由现金流/营收 | 12.2% | 6.0% |
| 资本支出强度资本支出/营收 | 2.9% | 1.2% |
| 现金转化率经营现金流/净利润 | 4.93× | 2.43× |
| 过去12个月自由现金流最近4个季度 | $110.0M | $36.3M |
8季度趋势，按日历期对齐
经营现金流LFSTPNTG
| Q4 25 | $57.6M | $21.0M | ||
| Q3 25 | $27.3M | $13.9M | ||
| Q2 25 | $64.4M | $34.6M | ||
| Q1 25 | $-3.1M | $-21.2M | ||
| Q4 24 | $62.3M | $20.6M | ||
| Q3 24 | $22.7M | $7.7M | ||
| Q2 24 | $44.1M | $10.5M | ||
| Q1 24 | $-21.8M | $545.0K |
自由现金流LFSTPNTG
| Q4 25 | $46.6M | $17.4M | ||
| Q3 25 | $17.0M | $10.5M | ||
| Q2 25 | $56.6M | $31.6M | ||
| Q1 25 | $-10.3M | $-23.2M | ||
| Q4 24 | $56.0M | $17.2M | ||
| Q3 24 | $17.7M | $6.8M | ||
| Q2 24 | $39.0M | $8.9M | ||
| Q1 24 | $-26.9M | $-2.6M |
自由现金流率LFSTPNTG
| Q4 25 | 12.2% | 6.0% | ||
| Q3 25 | 4.7% | 4.6% | ||
| Q2 25 | 16.4% | 14.4% | ||
| Q1 25 | -3.1% | -11.1% | ||
| Q4 24 | 17.2% | 9.1% | ||
| Q3 24 | 5.7% | 3.8% | ||
| Q2 24 | 12.5% | 5.3% | ||
| Q1 24 | -9.0% | -1.7% |
资本支出强度LFSTPNTG
| Q4 25 | 2.9% | 1.2% | ||
| Q3 25 | 2.8% | 1.5% | ||
| Q2 25 | 2.2% | 1.4% | ||
| Q1 25 | 2.2% | 0.9% | ||
| Q4 24 | 1.9% | 1.8% | ||
| Q3 24 | 1.6% | 0.5% | ||
| Q2 24 | 1.6% | 1.0% | ||
| Q1 24 | 1.7% | 2.0% |
现金转化率LFSTPNTG
| Q4 25 | 4.93× | 2.43× | ||
| Q3 25 | 25.34× | 2.29× | ||
| Q2 25 | — | 4.89× | ||
| Q1 25 | -4.36× | -2.73× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.24× | ||
| Q2 24 | — | 1.84× | ||
| Q1 24 | — | 0.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LFST
暂无分部数据
PNTG
| Home Health Subsegment | $136.2M | 47% |
| Hospice Subsegment | $97.1M | 34% |
| Private And Other | $36.4M | 13% |
| Medicare And Medicaid | $19.6M | 7% |
| Affiliated Entity | $2.2M | 1% |
